BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18612800)

  • 1. CD133 identifies perivascular niches in grade II-IV astrocytomas.
    Christensen K; Schrøder HD; Kristensen BW
    J Neurooncol; 2008 Nov; 90(2):157-70. PubMed ID: 18612800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
    Li MW; Niu CS
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133+ niches and single cells in glioblastoma have different phenotypes.
    Christensen K; Schrøder HD; Kristensen BW
    J Neurooncol; 2011 Aug; 104(1):129-43. PubMed ID: 21184132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays.
    He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM
    Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms.
    Schittenhelm J; Simon P; Harter PN; Zachskorn C; Schlaszus H; Röttger F; Winkels M; Weller M; Meyermann R; Mittelbronn M
    Histopathology; 2011 Apr; 58(5):739-49. PubMed ID: 21438906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer.
    Janikova M; Skarda J; Dziechciarkova M; Radova L; Chmelova J; Krejci V; Sedlakova E; Zapletalova J; Langova K; Klein J; Grygarkova I; Kolek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Dec; 154(4):321-6. PubMed ID: 21293543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
    Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
    J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.
    Sana J; Zambo I; Skoda J; Neradil J; Chlapek P; Hermanova M; Mudry P; Vasikova A; Zitterbart K; Hampl A; Sterba J; Veselska R
    Anal Cell Pathol (Amst); 2011; 34(6):303-18. PubMed ID: 22156015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glial stem cells and their relationship with tumour angiogenesis process].
    Bulnes S; García-Blanco Á; Bengoetxea H; Ortuzar N; Argandoña EG; Lafuente JV
    Rev Neurol; 2011 Jun; 52(12):743-50. PubMed ID: 21594859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between glioblastoma stem-like cells and tumor vascularization.
    He H; Niu CS; Li MW
    Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
    Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
    PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the clinical value of cancer stem cell markers in gliomas?
    Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the lysosomal-associated membrane protein-1 (LAMP-1) in astrocytomas.
    Jensen SS; Aaberg-Jessen C; Christensen KG; Kristensen B
    Int J Clin Exp Pathol; 2013; 6(7):1294-305. PubMed ID: 23826410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.
    Kim HS; Yoo SY; Kim KT; Park JT; Kim HJ; Kim JC
    Int J Clin Exp Pathol; 2012; 5(8):754-61. PubMed ID: 23071857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures.
    Aaberg-Jessen C; Nørregaard A; Christensen K; Pedersen CB; Andersen C; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(4):546-60. PubMed ID: 23573302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
    Ying Z; Gonzalez-Martinez J; Tilelli C; Bingaman W; Najm I
    Epilepsia; 2005 Nov; 46(11):1716-23. PubMed ID: 16302851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression.
    Hlobilkova A; Ehrmann J; Knizetova P; Krejci V; Kalita O; Kolar Z
    Neoplasma; 2009; 56(4):284-90. PubMed ID: 19473053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A; Lu C
    Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.